These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

569 related articles for article (PubMed ID: 22920963)

  • 21. Changes in relative cerebral blood volume 1 month after radiation-temozolomide therapy can help predict overall survival in patients with glioblastoma.
    Mangla R; Singh G; Ziegelitz D; Milano MT; Korones DN; Zhong J; Ekholm SE
    Radiology; 2010 Aug; 256(2):575-84. PubMed ID: 20529987
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Outcome of conventional treatment and prognostic factor in elderly glioblastoma patients.
    Oh SW; Jee TK; Kong DS; Nam DH; Lee JI; Seol HJ
    Acta Neurochir (Wien); 2014 Apr; 156(4):641-51. PubMed ID: 24553726
    [TBL] [Abstract][Full Text] [Related]  

  • 23. O(6) -methylguanine-DNA methyltransferase (MGMT) promoter methylation and low MGMT-encoded protein expression as prognostic markers in glioblastoma patients treated with biodegradable carmustine wafer implants after initial surgery followed by radiotherapy with concomitant and adjuvant temozolomide.
    Lechapt-Zalcman E; Levallet G; Dugué AE; Vital A; Diebold MD; Menei P; Colin P; Peruzzy P; Emery E; Bernaudin M; Chapon F; Guillamo JS
    Cancer; 2012 Sep; 118(18):4545-54. PubMed ID: 22359215
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combined modality treatment of newly diagnosed glioblastoma multiforme in a regional neurosurgical centre.
    Gauden AJ; Hunn A; Erasmus A; Waites P; Dubey A; Gauden SJ
    J Clin Neurosci; 2009 Sep; 16(9):1174-9. PubMed ID: 19540125
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Postoperative chemo-radiotherapy with temodal in patients with glioblastoma multiforme--survival rates and prognostic factors.
    Yaneva MP; Semerdjieva ML; Radev LR; Vlaikova MI
    Folia Med (Plovdiv); 2010; 52(1):26-33. PubMed ID: 20380284
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Independent association of extent of resection with survival in patients with malignant brain astrocytoma.
    McGirt MJ; Chaichana KL; Gathinji M; Attenello FJ; Than K; Olivi A; Weingart JD; Brem H; Quiñones-Hinojosa AR
    J Neurosurg; 2009 Jan; 110(1):156-62. PubMed ID: 18847342
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prospective trial of gross-total resection with Gliadel wafers followed by early postoperative Gamma Knife radiosurgery and conformal fractionated radiotherapy as the initial treatment for patients with radiographically suspected, newly diagnosed glioblastoma multiforme.
    Smith KA; Ashby LS; Gonzalez LF; Brachman DG; Thomas T; Coons SW; Battaglia M; Scheck A
    J Neurosurg; 2008 Dec; 109 Suppl():106-17. PubMed ID: 19123896
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management and Survival Patterns of Patients with Gliomatosis Cerebri: A SEER-Based Analysis.
    Carroll KT; Hirshman B; Ali MA; Alattar AA; Brandel MG; Lochte B; Lanman T; Carter B; Chen CC
    World Neurosurg; 2017 Jul; 103():186-193. PubMed ID: 28366748
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Conditional probability of survival in patients with newly diagnosed glioblastoma.
    Polley MY; Lamborn KR; Chang SM; Butowski N; Clarke JL; Prados M
    J Clin Oncol; 2011 Nov; 29(31):4175-80. PubMed ID: 21969507
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic value of MGMT promoter status in non-resectable glioblastoma after adjuvant therapy.
    Iaccarino C; Orlandi E; Ruggeri F; Nicoli D; Torricelli F; Maggi M; Cerasti D; Pisanello A; Pedrazzi G; Froio E; Crafa P; D'Abbiero N; Michiara M; Ghadirpour R; Servadei F
    Clin Neurol Neurosurg; 2015 May; 132():1-8. PubMed ID: 25723791
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adjuvant immunotherapy with whole-cell lysate dendritic cells vaccine for glioblastoma multiforme: a phase II clinical trial.
    Cho DY; Yang WK; Lee HC; Hsu DM; Lin HL; Lin SZ; Chen CC; Harn HJ; Liu CL; Lee WY; Ho LH
    World Neurosurg; 2012; 77(5-6):736-44. PubMed ID: 22120301
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of temozolomide as adjuvant chemotherapy after postsurgical radiotherapy alone for glioblastomas.
    Rhee DJ; Kong DS; Kim WS; Park KB; Lee JI; Suh YL; Song SY; Kim ST; Lim DH; Park K; Kim JH; Nam DH
    Clin Neurol Neurosurg; 2009 Nov; 111(9):748-51. PubMed ID: 19716649
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effectiveness of adjuvant temozolomide treatment in patients with glioblastoma.
    Alnaami IM; Al-Nuaimi SK; Senthilselvan A; Murtha AD; Walling S; Mehta V; Gourishankar S
    Neurosciences (Riyadh); 2013 Oct; 18(4):349-55. PubMed ID: 24141458
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic and predictive value of p53 in low MGMT expressing glioblastoma treated with surgery, radiation and adjuvant temozolomide chemotherapy.
    Li S; Zhang W; Chen B; Jiang T; Wang Z
    Neurol Res; 2010 Sep; 32(7):690-4. PubMed ID: 19703338
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MGMT gene promoter methylation as a potent prognostic factor in glioblastoma treated with temozolomide-based chemoradiotherapy: a single-institution study.
    Kim YS; Kim SH; Cho J; Kim JW; Chang JH; Kim DS; Lee KS; Suh CO
    Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):661-7. PubMed ID: 22414280
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic factors and survival study in high-grade glioma in the elderly.
    Álvarez de Eulate-Beramendi S; Álvarez-Vega MA; Balbin M; Sanchez-Pitiot A; Vallina-Alvarez A; Martino-González J
    Br J Neurosurg; 2016 Jun; 30(3):330-6. PubMed ID: 26828095
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognosis factors of survival time in patients with glioblastoma multiforme: a multivariate analysis of 340 patients.
    Mineo JF; Bordron A; Baroncini M; Ramirez C; Maurage CA; Blond S; Dam-Hieu P
    Acta Neurochir (Wien); 2007 Mar; 149(3):245-52; discussion 252-3. PubMed ID: 17273889
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Encouraging experience of concomitant Temozolomide with radiotherapy followed by adjuvant Temozolomide in newly diagnosed glioblastoma multiforme: single institution experience.
    Jalali R; Basu A; Gupta T; Munshi A; Menon H; Sarin R; Goel A
    Br J Neurosurg; 2007 Dec; 21(6):583-7. PubMed ID: 18071985
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cystic glioblastoma: an evaluation of IDH1 status and prognosis.
    Sarmiento JM; Nuño M; Ortega A; Mukherjee D; Fan X; Black KL; Patil CG
    Neurosurgery; 2014 Jan; 74(1):71-5: discussion 75-6. PubMed ID: 24089051
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improved survival of Swedish glioblastoma patients treated according to Stupp.
    Bruhn H; Strandéus M; Milos P; Hallbeck M; Vrethem M; Lind J
    Acta Neurol Scand; 2018 Oct; 138(4):332-337. PubMed ID: 29882211
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.